Series A funding round for Delix Therapeutics raising $70M in September 2021
Series A funding round for Delix Therapeutics raising $70M in September 2021
| Investor | Firm Type | Partner |
|---|
| Private | — | |
OMX VenturesLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Family Office | — | |
| Venture Capital | — | |
| Syndicate | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Vasudev Bailey |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$110M
Top Valuation
-
Delix Therapeutics raised $70M in a Series A round.
The round was announced on 09/01/21.
The round was led by OMX Ventures, Andrew Levin.